TY  - JOUR 
AU  - Martín Blázquez, Ariadna
AU  - Jiménez Luna, Cristina
AU  - Díaz, Caridad
AU  - Martínez-Galán, Joaquina
AU  - Prados Salazar, José Carlos
AU  - Vicente, Francisca
AU  - Melguizo Alonso, Consolación
AU  - Genilloud Rodríguez, Olga
AU  - Pérez del Palacio, José
AU  - Caba Pérez, Octavio
PY  - 2020
UR  - http://hdl.handle.net/10481/62454
AB  - Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal cancers,
with a 5-year survival rate of less than 5%. In fact, complete surgical resection remains the only
curative treatment. However, fewer than 20% of patients are...
LA  - eng
PB  - MDPI
KW  - Metabolomics
KW  - Pancreatic ductal adenocarcinoma
KW  - Reverse-phase liquid chromatography
KW  - Biomarker
KW  - Diagnosis
TI  - Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
DO  - doi:10.3390/cancers12041002
ER  -